NCT05542550 is a NA clinical trial of Voice Rest in Vocal Cord Paralysis, sponsored by University of Virginia.

Who is sponsoring NCT05542550?

NCT05542550 is sponsored by University of Virginia.

What drugs are being tested in NCT05542550?

Interventions in NCT05542550: Voice Rest, No Voice Rest.

What condition does NCT05542550 study?

NCT05542550 studies Vocal Cord Paralysis.

Is NCT05542550 still recruiting?

NCT05542550 is currently status unknown. Last updated 19 January 2024.

Last reviewed 2024-01-19 · How we verify

NCT05542550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Voice Rest and Injection Laryngoplasty

Status unknown NA Last updated 19 January 2024

What this trial tests

NA trial testing Voice Rest in Vocal Cord Paralysis in 150 participants. Status unknown.

Timeline

1 August 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	University of Virginia
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	150
Start date	1 August 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across United States

Drugs / interventions tested

Voice Rest
No Voice Rest

Conditions studied

Vocal Cord Paralysis — all drugs for Vocal Cord Paralysis →

Sponsor

University of Virginia

Who can join

Adults 18 to 89, any sex, with Vocal Cord Paralysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the subjective, objective, and aerodynamic impact of voice rest following injection augmentation and compare the outcomes to patients with no post-procedure voice restrictions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vocal Cord Paralysis

Currently open trials in the same condition.

NCT06406725 — Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure · recruiting

Other University of Virginia trials

Trials by the same sponsor.

NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI · EARLY_PHASE1 · not yet recruiting
NCT07405645 — Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy · NA · recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
NCT07298941 — Resilience Enhancement Following Sleep Treatment · Phase 2 · recruiting
NCT07036315 — Meaning in Music-Based Pain Modulation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05542550 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Virginia
Last refreshed: 19 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05542550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing